Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex

Wellens, H. J. J., Bär, F. W. H. M., & Lie, K. I. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90176-6 · Cited by 538 · see citing works

Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers

Ikeda, N., Singh, B. N., Davis, L. D., & Hauswirth, O. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80051-6 · Cited by 97 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): <i>Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society</i>

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805 · see citing works

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,963 · see citing works

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,883 · see citing works

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,358 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,157 · see citing works

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 921 · see citing works

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859 · see citing works

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · EP Europace · doi:10.1093/europace/eul108 · Cited by 735 · see citing works

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 750 · see citing works

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · EP Europace · doi:10.1093/europace/eul097 · Cited by 663 · see citing works

Management of Patients With Atrial Fibrillation

Prystowsky, E. N., Benson, D. W., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1262 · Cited by 643 · see citing works

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary

Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 645 · see citing works

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 639 · see citing works

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 607 · see citing works

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 489 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.018 · Cited by 465 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177031 · Cited by 341 · see citing works

Management of Atrial Fibrillation

Wood, A. J. J., & Pritchett, E. L. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261906 · Cited by 322 · see citing works

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

Crijns, H. J. G. M., Gelder, I. C. V., van Gilst, W. H., Hillege, H. L., Gosselink, A. M., & Lie, K. I. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90828-9 · Cited by 275 · see citing works

Rate control in atrial fibrillation

Gelder, I. C. V., Rienstra, M., Crijns, H. J. G. M., & Olshansky, B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31258-2 · Cited by 206 · see citing works

Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter

Gelder, I. C. V., Crijns, H. J. G. M., van Gilst, W. H., van Wijk, L. M., Hamer, H. P. M., & Lie, K. I. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90574-2 · Cited by 187 · see citing works

European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)

Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188 · see citing works

Proarrhythmia in Patients Treated for Atrial Fibrillation or Flutter

Falk, R. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-141 · Cited by 184 · see citing works

Flecainide-Induced Ventricular Tachycardia and Fibrillation in Patients Treated for Atrial Fibrillation

Falk, R. H. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-2-107 · Cited by 183 · see citing works

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

Naccarelli, G. V., Wolbrette, D. L., Khan, M. R., Bhatta, L., Hynes, J. K., Samii, S. M., & Luck, J. C. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03375-1 · Cited by 172 · see citing works

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

Aliot, E., Capucci, A., Crijns, H. J. G. M., Goette, A., & Tamargo, J. L. (2010) · EP Europace · doi:10.1093/europace/euq382 · Cited by 168 · see citing works

Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

Feld, G. K., Chen, P., NICOD, P. H., FLECK, R. P., & Meyer, D. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90856-v · Cited by 147 · see citing works

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter

Naccarelli, G. V., Dorian, P., Hohnloser, S. H., & Coumel, P. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89118-7 · Cited by 134 · see citing works

Mechanisms and management of proarrhythmia

Roden, D. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00472-x · Cited by 128 · see citing works

Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.

Gelder, I. C. V., Hagens, V. E., Kingma, J. H., Bosker, H. A., Otto Kamp, B., Kingma, T., Veeger, N. J. G. M., Bouma, J., TenVergert, E. M., Tijssen, J. G. P., et al. (2002) · PubMed Central · Cited by 125 · see citing works

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Brandes, A., Crijns, H. J. G. M., Rienstra, M., Kirchhof, P. F., Grove, E. L., Pedersen, K. B., & Gelder, I. C. V. (2020) · EP Europace · doi:10.1093/europace/euaa057 · Cited by 122 · see citing works

Atrial flutter in patients treated for atrial fibrillation with propafenone

Murdock, C. J., Kyles, A. E., Yeung-Lai-Wah, J. A., Qi, A., Vorderbrugge, S., & Kerr, C. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91144-u · Cited by 114 · see citing works

Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation

Pritchett, E. L. C., Page, R. L., Carlson, M. D., Undesser, K. P., & Fava, G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00974-3 · Cited by 105 · see citing works

Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response

Pritchett, E. L. C., Page, R. L., Connolly, S. J., Marcello, S. R., Schnell, D., & Wilkinson, W. E. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00773-7 · Cited by 102 · see citing works

Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation

Schumacher, B. M., Jung, W., Lewalter, T., Vahlhaus, C., Wolpert, C., & Lüderitz, B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00975-8 · Cited by 101 · see citing works

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

Merino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 105 · see citing works

Diagnostic criteria of broad QRS complex tachycardia: decades of evolution

Alzand, B. S. N., & Crijns, H. J. G. M. (2011) · Europace · doi:10.1093/europace/euq430 · Cited by 93 · see citing works

Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens

Botto, G. L., Capucci, A., Bonini, W., Boriani, G., BROFFONI, T., Barone, P., Espureo, M., Lombardi, R., Molteni, S., & Ferrari, G. M. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02841-0 · Cited by 77 · see citing works

Proarrhythmia

Friedman, P. L., & Stevenson, W. G. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00586-4 · Cited by 70 · see citing works

Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation

Blanc, J., Voinov, C., & Maarek, M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00493-2 · Cited by 69 · see citing works

Antiarrhythmic drugs: from mechanisms to clinical practice

Roden, D. M. (2000) · Heart · doi:10.1136/heart.84.3.339 · Cited by 58 · see citing works

Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias

Brembilla-Perrot, B., Houriez, P., Beurrier, D., Claudon, O., Chaise, A. T. D. L., & Louis, P. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00459-4 · Cited by 56 · see citing works

Regular Ventricular Rhythms Before Conversion of Recent Onset Atrial Fibrillation to Sinus Rhythm

Botto, G., Bonini, W., BROFFONI, T., CAPPELLETTI, G. A., Falcone, C., LOMBARDI, R., Paulesu, A., PEDRAGLIO, E., & Ferrari, G. M. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb03810.x · Cited by 56 · see citing works

Clinical Pharmacokinetics of Propafenone

Hii, J. T. Y., Duff, H. J., & Burgess, E. D. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121010-00001 · Cited by 55 · see citing works

Pharmacology and Toxicology of Nav1.5-Class 1 Antiarrhythmic Drugs

Roden, D. M. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2014.07.003 · Cited by 48 · see citing works

Flecainide Toxicity: A Case Report and Systematic Review of its Electrocardiographic Patterns and Management

Valentino, M. A., Panakos, A., Ragupathi, L., Williams, J. L., & Pavri, B. B. (2016) · Cardiovascular Toxicology · doi:10.1007/s12012-016-9380-0 · Cited by 47 · see citing works

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:XX-XX.33This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (www.americanheart.org), the European Society of Cardiology (www.escardio.org), and the North American Society of Pacing and Electrophysiology (www.naspe.org). Single reprints of this document (the complete Guidelines) to be published in the mid-October issue of the European Heart Journal are available by calling +44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines – Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. Single reprints of the shorter version (Executive Summary and Summary of Recommendations) published in the October issue of the Journal of the American College of Cardiology and the October issue of Circulation, are available for $5.00 each by calling 800-253-4636 (US only) or by writing the Resource Center, American College of Cardiology, 9111 Old Georgetown Road, Bethesda, Maryland 20814. To purchase bulk reprints specify version and reprint number (Executive Summary 71-0208; full text 71-0209) up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org.

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01586-8 · Cited by 46 · see citing works

Conversion of Recent Onset Atrial Fibrillation with Single Loading Oral Dose of Propafenone: Is In‐Hospital Admission Absolutely Necessary?

Botto, G. L., Bonini, W., BROFFONI, T., Molteni, S., LOMBARDI, R., ALFIERI, G., Barone, P., Bernasconi, G., & Ferrari, G. M. (1996) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1996.tb03257.x · Cited by 44 · see citing works

Flecainide

Falk, R. H., & Fogel, R. I. (1994) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1994.tb01136.x · Cited by 39 · see citing works

Antiarrhythmic Drug Therapy in the Management of Atrial Fibrillation

Ganz, L. I., & Antman, E. M. (1997) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1997.tb01005.x · Cited by 38 · see citing works

Approach to the Diagnosis and Initial Management of the Stable Adult Patient With a Wide Complex Tachycardia

Goldberger, Z. D., Rho, R. W., & Page, R. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.024 · Cited by 34 · see citing works

Proarrhythmia

Roden, D. M., & Anderson, M. E. (2006) · Springer eBooks · doi:10.1007/3-540-29715-4_3 · Cited by 31 · see citing works

Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs

Kawabata, M., Hirao, K., Horikawa, T., Suzuki, K., Motokawa, K., Suzuki, F., Azegami, K., & Hiejima, K. (2001) · Journal of Electrocardiology · doi:10.1054/jelc.2001.22034 · Cited by 29 · see citing works

Is There a Future for Antiarrhythmic Drug Therapy?

Guerra, P. G., Talajic, M. R., Roy, D., Dubuc, M., Thibault, B., & Nattel, S. (1998) · Drugs · doi:10.2165/00003495-199856050-00003 · Cited by 25 · see citing works

Effect of Drugs on the Electrocardiogram

(2008) · Elsevier eBooks · doi:10.1016/b978-141603774-3.10021-8 · Cited by 26 · see citing works

Adverse Effects of Class I Antiarrhythmic Drugs

Caron, J., & Libersa, C. (1997) · Drug Safety · doi:10.2165/00002018-199717010-00002 · Cited by 25 · see citing works

Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias

Lavalle, C., Magnocavallo, M., Straito, M., Santini, L., Forleo, G. B., Grimaldi, M., Badagliacca, R., Lanata, L., & Ricci, R. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071456 · Cited by 24 · see citing works

Antiarrhythmic Drugs:

Roden, D. M. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03441.x · Cited by 23 · see citing works

Regular ventricular rhythms in patients with symptomatic paroxysmal atrial fibrillation

Weiner, H. L., McCarthy, E. A., & Pritchett, E. L. C. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80136-6 · Cited by 23 · see citing works

Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives

Lavalle, C., Trivigno, S., Vetta, G., Magnocavallo, M., Mariani, M. V., Santini, L., Forleo, G. B., Grimaldi, M., Badagliacca, R., Lanata, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163696 · Cited by 22 · see citing works

ACC/AHA/ESC: Guías de Práctica Clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida

Informe del Grupo de Trabajo para la elaboración de guías de práctica clínica del American College of Cardiology y de la American Heart Association, del Comité de Guías de Práctica Clínica de la Sociedad Europea de Cardiología (comité de redacción para la revisión de la Guía de práctica clínica sobre el manejo de pacientes con fibrilación auricular, 2., & Desarrollado en colaboración con las asociaciones European Heart Rhythm Association y Heart Rhythm Society (2006) · Revista Española de Cardiología · doi:10.1157/13096583 · Cited by 20 · see citing works

Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity

Nogales‐Asensio, J. M., Sánchez, N. M., Doncel-Vecino, L. J., Mariscal, C. V., López-Mínguez, J. R., & Herrera, A. M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.124 · Cited by 19 · see citing works

Is There a Role for Maintaining Sinus Rhythm in Patients with Atrial Fibrillation?

ZIMETBAUM, P. J., & Josephson, M. E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-9-200411020-00015 · Cited by 19 · see citing works

Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses

Carstensen, H., Hesselkilde, E. M., Fenner, M. F., Loft‐Andersen, A. V., Flethøj, M., Kanters, J. K., Sattler, S. M., Tfelt‐Hansen, J., Pehrson, S. M., Jespersen, T., et al. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15287 · Cited by 18 · see citing works

THE MEDICAL MANAGEMENT OF ATRIAL FIBRILLATION

Masoudi, F. A., & Goldschlager, N. (1997) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70370-2 · Cited by 17 · see citing works

Antiarrhythmic drug initiation in patients with atrial fibrillation

Pinski, S. L., & Helguera, M. E. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70010-1 · Cited by 14 · see citing works

Atrial fibrillation: New management strategies

Pai, S. M., & Torres, V. I. (1993) · Current Problems in Cardiology · doi:10.1016/0146-2806(93)90024-v · Cited by 14 · see citing works

Safety and Efficacy of Oral Flecainide Acetate in Patients with Cardiac Arrhythmias.

Nakazato, Y., Nakata, Y., Yasuda, M., Nakazato, K., Sumiyoshi, M., Ogura, S., & Yamaguchi, H. (1997) · Japanese Heart Journal · doi:10.1536/ihj.38.379 · Cited by 13 · see citing works

Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study

Er, F., Aslan, O., Caglayan, E., Gassanov, N., Nia, A. M., Erdmann, E., & Rosenkranz, S. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0129-7 · Cited by 12 · see citing works

Atrial Fibrillation and Flutter

Brady, P. A., & Gersh, B. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_95 · Cited by 12 · see citing works

Oral antiarrhythmic drugs in converting recent onset atrial fibrillation

Deneer, V. H. M., Borgh, M. B. I., Kingma, J. H., Lie‐A‐Huen, L., & Brouwers, J. R. B. J. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000018593.02291.c0 · Cited by 12 · see citing works

Flecainide Induced Atrial Tachycardia with 1:1 Ventricular Conduction During Exercise Testing

Randazzo, D. N., Schweitzer, P., STEIN, E., Banas, J. S., & Winters, S. L. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb01516.x · Cited by 12 · see citing works

Antiarrhythmic drug treatment: need for continuous vigilance.

Wellens, H. J. J., Smeets, J. L. R. M., Vos, M. A., & Gorgels, A. P. M. (1992) · Heart · doi:10.1136/hrt.67.1.25 · Cited by 12 · see citing works

Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks

Loomba, R. S., Singh, A. K., Kovach, J. R., & Gudausky, T. M. (2014) · Cardiology in the Young · doi:10.1017/s1047951114001188 · Cited by 11 · see citing works

AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION (ENDING)

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. Y. L., Kay, G. N., Lowe, J. E., et al. (2007) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2007-3-3-84-111 · Cited by 11 · see citing works

Right bundle branch block–type wide QRS complex tachycardia with a reversed R/S complex in lead V6: Development and validation of electrocardiographic differentiation criteria

Kim, M., Kwon, C. H., Lee, J. H., Hwang, K. W., Choi, H. O., Kim, Y., Lee, K., Ahn, J., Park, H., & Nam, G. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.08.023 · Cited by 10 · see citing works

Limitations of the negative concordance pattern in the diagnosis of broad QRS tachycardia

Barold, S. S., Stroobandt, R. X., & Herweg, B. (2012) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2012.06.017 · Cited by 9 · see citing works

Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation

Limantoro, I., de Vos, C. B., Delhaas, T., Marcos, E. G., Blaauw, Y., Weijs, B., Tieleman, R. G., Pisters, R., Schotten, U., Gelder, I. C. V., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.12.010 · Cited by 8 · see citing works

Complex Arrhythmias Due to Reversible Causes

Pozzolini, A., Rio, T., Padeletti, M., Ponti, R. D., Leonelli, F. M., & Bagliani, G. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.03.002 · Cited by 8 · see citing works

Wide Complex Tachycardia in the Presence of Class I Antiarrhythmic Agents: A Diagnostic Challenge

Bhardwaj, B., Lazzara, R., & Stavrakis, S. (2013) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12099 · Cited by 8 · see citing works

Bedside Diagnosis of Wide QRS Tachycardia

Barold, S. S. (1995) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1995.tb04634.x · Cited by 8 · see citing works

Long‐term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide‐induced atrial flutter

Hirao, K., Okishige, K., Yamamoto, N., Otomo, K., Azegami, K., & Isobe, M. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280707 · Cited by 7 · see citing works

Class I Antiarrhythmic Drugs: Na+ Channel Blockers

Shenasa, M., Shenasa, M.-A., & Smith, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-34893-9_2 · Cited by 6 · see citing works

Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion

Colangelo, T., Johnson, D. M., & Ho, R. T. (2021) · Texas Heart Institute Journal · doi:10.14503/thij-19-7099 · Cited by 6 · see citing works

Antiarrhythmic Drugs

Roden, D. M., Darbar, D., & Kannankeril, P. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_102 · Cited by 6 · see citing works

Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: Ventricular or supraventricular proarrhythmia?

Wiesfeld, A. C. P., Ansink, J. M., van Veldhuisen, D. J., & Gelder, I. C. V. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.033 · Cited by 6 · see citing works

Positive inotropic drugs and drugs used in dysrhythmias

Aronson, J. K. (2004) · Side effects of drugs annual · doi:10.1016/s0378-6080(04)80024-2 · Cited by 6 · see citing works

Characteristics of Patients with Chronic Atrial Fibrillation and the Prediction of Successful DC Electrical Cardioversion

Gelder, I. C. V., Crijns, H. J. G. M., & Lie, K. I. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1816-3_5 · Cited by 6 · see citing works

Ambient pollutants as adjuvant for allergic sensitization: the emerging role of platinum group elements.

Burastero, S. E., Paolucci, C., & Fabbri, M. (2009) · PubMed · Cited by 6 · see citing works

Rhythm Association and the Heart Rhythm Society Developed in Collaboration With the European Heart Atrial Fibrillation): Committee to Revise the 2001 Guidelines for the Management of Patients With the European Society of Cardiology Committee for Practice Guidelines (Writing Cardiology/American Heart Association Task Force on Practice Guidelines and Fibrillation—Executive Summary: A Report of the American College of ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial

Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, L., Despres, C., Dickstein, K., Lekakis, J. P., McGregor, K., Metra, M., Budaj, A., et al. (2006) · Cited by 5 · see citing works

Antiarrhythmic Drugs:

Roden, D. M. (2003) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2003.00375.x · Cited by 5 · see citing works

Еlectrocardiographic criteria and algorithms for differential diagnosis of wide QRS complexes arrhythmias

Budanova, M. A., Chmelevsky, M. P., Treshkur, T. V., & Тихоненко, В. М. (2021) · Journal of Arrhythmology · doi:10.35336/va-2020-4-24-32 · Cited by 3 · see citing works

Supraventricular Tachycardia: Electrocardiogram Diagnosis and Clinical Management for the Non-electrophysiologist

Boehmer, A. A., Rothe, M., Soether, C. M., Kaess, B. M., & Ehrlich, J. R. (2021) · European Journal of Arrhythmia & Electrophysiology · doi:10.17925/ejae.2021.7.1.4 · Cited by 3 · see citing works

The World of Pacing and Electropysiology: Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation

Saskena, S., DOMANSKI, M. J., Benjamin, E. J., Camm, A. J., Ezekowitz, M. D., Gersh, B. J., Jalife, J., Naccarelli, G. V., Vlietstra, R. E., & Wyse, D. G. (2001) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/a:1011489306778 · Cited by 3 · see citing works

Plasma viscosity, fibrinogen, white cell count, and cardiovascular risk factors.

Jay, R. H., RAMPLING, M. W., & Betteridge, D. J. (1992) · Circulation · doi:10.1161/circ.85.5.1572057 · Cited by 3 · see citing works

Drug Effects on ECGs

Bonelli, P., Giannini, I., Matassini, M. V., & Menditto, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-91677-4_13 · Cited by 2 · see citing works

Fibrinogen, viscosity, and white blood cell count.

Ernst, E. (1992) · Circulation · doi:10.1161/circ.85.5.1572056 · Cited by 2 · see citing works

Diagnóstico diferencial de las taquicardias de complejo ancho: un desafío permanente

René Asenjo, G., Morris, R., Sanhueza, E. J., Ortiz, M. A., & Cereceda, M. (2020) · Revista chilena de cardiología · doi:10.4067/s0718-85602020000100055 · Cited by 2 · see citing works

Maintaining stability of sinus rhythm in atrial fibrillation: Antiarrhythmic drugs versus ablation

Naccarelli, G. V., Hynes, J. K., Wolbrette, D. L., Bhatta, L., Khan, M. R., & Luck, J. C. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0042-4 · Cited by 2 · see citing works

In-Hospital Approach to Newly Recognized Atrial Fibrillation

Kimmelstiel, C. D., Homoud, M. K., Clyne, C. A., & Estes, M. (1999) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008825318341 · Cited by 1 · see citing works

Class IC Atrial Flutter Presenting as a Wide Complex Tachycardia: Lessons from a Case Report

Aurrecoechea-Perea, M., Ayala-More, H. D., Valdivia, I. V., Gonzalo-Moreno, T., & Gota-Nieto, M. (2026) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2026.0009

Alternating bizarrely–shaped broad QRS complex tachycardia. What is the mechanism?

Alzand, B. S. N. (2012) · Netherlands Heart Journal · doi:10.1007/s12471-012-0262-1

A broad complex tachycardia in a patient on flecainide

Chatterjee, D. (2021) · British Journal of Cardiology · doi:10.5837/bjc.2021.034

Flecainide induced ventricular fibrillation in a neonate

Ackland, F. M., Singh, R., & Thayyil, S. (2003) · Heart · doi:10.1136/heart.89.10.1261 · Cited by 11 · see citing works

Flecainide Induced Atrial Tachycardia with 1:1 Ventricular Conduction During Exercise Testing

Randazzo, D. N., Schweitzer, P., STEIN, E., Banas, J. S., & Winters, S. L. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb01516.x · Cited by 12 · see citing works